In the BioHarmony Drug Report Database

"Preview" Icon

Metaproterenol

Alupent (metaproterenol) is a small molecule pharmaceutical. Metaproterenol was first approved as Alupent on 1982-01-01. It is used to treat asthma, bronchial spasm, chronic bronchitis, and pulmonary emphysema in the USA. The pharmaceutical is active against beta-2 adrenergic receptor.

 

Trade Name

 

Alupent
 

Common Name

 

metaproterenol
 

ChEMBL ID

 

CHEMBL776
 

Indication

 

asthma, bronchial spasm, chronic bronchitis, pulmonary emphysema
 

Drug Class

 

Image (chem structure or protein)

Metaproterenol structure rendering